Concepedia

Akash Ashokan

AA

3

Publications

46

Citations

3

H-Index

2023

Active since

Affiliations

Nanotherapeutics (United States)(Current)

University of Miami

Sylvester Comprehensive Cancer Center

Akash Ashokan is an author at Nanotherapeutics (United States) specializing in drug discovery, metabolic regulation, and tumor biology.

ORCID

Top concepts

Publications per year

2023–2024

3

Publications

3

New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance

Akil A. Kalathil, Subham Guin, Akash Ashokan et al. · ACS Central Science · 2023 · 22 citations · Full text

, , +22

Simultaneous targeting of peripheral and brain tumors with a therapeutic nanoparticle to disrupt metabolic adaptability at both sites

Akash Ashokan, Shrita Sarkar, Mohammad Zahid Kamran et al. · Proceedings of the National Academy of Sciences · 2024 · 13 citations · Full text

Platin-<i>C</i> containing nanoparticles: a recipe for the delivery of curcumin–cisplatin combination chemotherapeutics to mitochondria

Bhabatosh Banik, Akash Ashokan, Joshua H. Choi et al. · Dalton Transactions · 2023 · 11 citations

Rows per page

1–3 of 3